日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models

揭示VAV1在人类癌症中的致癌潜力:来自小鼠模型的启示

Shalom, Batel; Salaymeh, Yaser; Risling, Matan; Katzav, Shulamit

Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice

Vav1 和突变型 K-Ras 在小鼠胰腺导管腺癌的早期发展中具有协同作用

Salaymeh, Yaser; Farago, Marganit; Sebban, Shulamit; Shalom, Batel; Pikarsky, Eli; Katzav, Shulamit

Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes

在人类癌症中发现的Vav1突变会导致不同的致癌表型。

Shalom, Batel; Farago, Marganit; Pikarsky, Eli; Katzav, Shulamit

Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer

Vav1:一种双重性格的蛋白质——对造血系统有益,对癌症有害。

Katzav, Shulamit

Mutation of Vav1 adaptor region reveals a new oncogenic activation

Vav1衔接蛋白区域的突变揭示了一种新的致癌激活机制。

Razanadrakoto, Lyra; Cormier, Françoise; Laurienté, Vanessa; Dondi, Elisabetta; Gardano, Laura; Katzav, Shulamit; Guittat, Lionel; Varin-Blank, Nadine

Mutations of c-Cbl in myeloid malignancies

髓系恶性肿瘤中 c-Cbl 的突变

Katzav, Shulamit; Schmitz, M Lienhard

Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Vav1 羧基末端的酪氨酸残基在其生物活性的调节中起着重要作用

Lazer Galit, Pe'er Liron, Farago Marganit, Machida Kazuya, Mayer Bruce J, Katzav Shulamit